Protagonist Therapeutics (PTGX) CEO Dinesh V. Patel Sells $7.5M Shares

Dinesh V. Patel, the CEO of Protagonist Therapeutics (PTGX), has sold $7.5 million in shares of the company. This transaction is significant as it may indicate changes in the company's leadership confidence or liquidity events. The sale of shares by an executive can have potential implications for investor sentiment and stock performance. Investors typically monitor such transactions closely, as they can affect trading volumes and market perception.